NCT07153159View on ClinicalTrials.gov

A Study to Learn How the Study Medicine Called Etrasimod is Taken up Into Blood and Breastmilk of Healthy Breastfeeding Women

PHASE1RecruitingINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

August 7, 2025

Primary Completion Date

September 12, 2026

Study Completion Date

October 12, 2026

Conditions
Healthy Participant
Interventions
DRUG

Etrasimod

Oral 2 milligrams tablet, once a day for 7 days

Trial Locations (1)

B-1070

RECRUITING

Pfizer Clinical Research Unit - Brussels, Brussels

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT07153159 - A Study to Learn How the Study Medicine Called Etrasimod is Taken up Into Blood and Breastmilk of Healthy Breastfeeding Women | Biotech Hunter | Biotech Hunter